Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 1.48
-3.27 %
$ 6.49 M
Market Cap
-0.64
P/E
BALANCE SHEET
13.8 M
ASSETS
5.6 M
LIABILITIES
8.33 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Intelligent Bio Solutions Inc.
| Current Assets | 8.53 M |
| Cash & Short-Term Investments | 6.3 M |
| Receivables | 978 K |
| Other Current Assets | 1.25 M |
| Non-Current Assets | 5.24 M |
| Long-Term Investments | 0 |
| PP&E | 873 K |
| Other Non-Current Assets | 4.37 M |
| Current Liabilities | 5.45 M |
| Accounts Payable | 602 K |
| Short-Term Debt | 1.06 M |
| Other Current Liabilities | 3.78 M |
| Non-Current Liabilities | 145 K |
| Long-Term Debt | 81.3 K |
| Other Non-Current Liabilities | 63.6 K |
Balance Sheet
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 6.3 | 1.5 | 8.2 | 12.6 | 0.4 | 0.2 | 0.4 | 56 K |
| Short Term Investments | 0 | 0.1 | 46.6 K | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.0 | 0.8 | 2.5 | 3.2 | 19.6 K | 94.5 K | 36.5 K | 0 |
| Inventory | 0.8 | 1.0 | 1 | (3.2) | 1.9 | 2.0 | 2.0 | 0 |
| Other Current Assets | 0.5 | 0.5 | 0.1 | 2.4 | 1.9 | 53.8 K | 2.0 | 0.6 |
| Total Current Assets | 8.5 | 3.9 | 10.9 | 16.4 | 2.3 | 2.3 | 2.5 | 0.7 |
| PP&E | 0.9 | 1.2 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.4 | 5.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 1.1 | 3.1 | 0.1 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 0 | 0 | 0.9 | 0 | 2.0 | 2.0 | 0.6 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | (2.0) | (2.0) | (0.6) |
| Total Assets | 13.8 | 10.4 | 12.4 | 20.4 | 2.5 | 2.3 | 2.5 | 0.7 |
| LIABILITIES | ||||||||
| Accounts Payable | 0.6 | 1.2 | 0.7 | 1.4 | 0.5 | 0.8 | 0.2 | 0.3 |
| Short Term Debt | 1.1 | 0.8 | 0 | 0 | 5.1 | 5.1 | 4.8 | 3.5 |
| Other Current Liabilities | 1.2 | 1.5 | 3.9 | 2.3 | 2.1 | 0.3 | 0.6 | 2.7 |
| Total Current Liabilities | 5.5 | 5.9 | 4.7 | 3.7 | 7.7 | 6.3 | 5.6 | 6.6 |
| Long Term Debt | 81.3 K | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 63.6 K | (0.3) | 50.6 K | 21.8 K | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.6 | 6.7 | 5.8 | 6.9 | 7.7 | 6.3 | 5.6 | 6.6 |
| EQUITY | ||||||||
| Common Stock | 34.6 K | 23.3 K | 0.1 | 0.1 | 2.9 | 2.0 | 1 | 1 |
| Retained Earnings | (52.0) | (41.8) | (31.2) | (24.3) | (15.8) | (12.7) | (5.3) | (0.3) |
| Other Accumulative Comprehensive Income/Loss | (0.7) | (0.6) | (0.8) | (0.7) | (0.4) | (0.2) | 0.6 | 2.72 K |
| Total Equity | 8.2 | 3.7 | 6.5 | 13.5 | (5.2) | (4.0) | (3.1) | (5.9) |
| Total Liabilities and Equity | 13.8 | 10.4 | 12.4 | 20.4 | 2.5 | 2.3 | 2.5 | 0.7 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 1.6 | 1.0 | 0.7 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 |